Skip to content
Pharma Observatory a Scientist.com platform

Organization (Academic)

Chengdu Sport University

ClinicalTrials.gov lists Chengdu Sport University as lead sponsor of 13 trials. It has 7 active development programs.

CN Academic
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

5 0 2021 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 2 registered with a 2026 start date. The dashed outline is the pace from the 2 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 2.6 trial starts a year over the five years to September, under the 5 a year the method needs.

This page covers Chengdu Sport University: 13 lead-sponsored trials and 1 legal-entity registration.

Get the Chengdu Sport University report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (9)

Shown in this order: most trials first.

Disease areas
Disease area Trials
COVID-19 2
Osteoarthritis 2
Osteoarthritis, Knee 2
Post-Acute COVID-19 Syndrome 2
Weight Loss 2

Showing 5 of 9 disease areas.

Start your 14-day trial Email me all 9 disease areas as a PDF

Trials by start year as sponsor or collaborator (5)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 2
2025 3
2024 5
2023 3
2021 1

Recruitment duration, a model prediction: none of the 13 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Active development programs (7)

Shown in this order: max phase, then active trials.

Active development programs
Drug Disease area Max phase Trials
Experimental Group Weight Loss Not reported 2
Control (placebo) group Weight Loss Not reported 1
Assigned Interventions COVID-19 Not reported 1
PLATELET RICH PLASMA Osteoarthritis Not reported 1
PLATELET RICH PLASMA Osteoarthritis, Knee Not reported 1

Showing 5 of 7 active programs.

Start your 14-day trial Email me all 7 active programs as a PDF

Latest dated events (14)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-07 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-05-15 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-09-20 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-04-15 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-02-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 14 events.

Start your 14-day trial Email me all 14 events as a PDF

Biomarker capability evidence (6)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
SULT1E1 Trial sponsor Named in trial inclusion criteria
SULT1E1 Trial sponsor Named in trial inclusion criteria
PRF1 Trial sponsor Named in trial exclusion criteria
PRF1 Trial sponsor Mentioned in trial text
SULT1E1 Trial sponsor Mentioned in trial text

Showing 5 of 6 evidence rows.

Start your 14-day trial Email me all 6 evidence rows as a PDF

Biomarkers this organization publishes on (17)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
TNF 2
ACE2 1
BAG3 1
BDNF 1
CRP 1

Showing 5 of 17 biomarkers.

Start your 14-day trial Email me all 17 biomarkers as a PDF

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, approved assets, sponsor delivery record, journals published in, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, and clia clinical laboratory certificates.